Metabolic associated fatty liver disease (MAFLD) has been identified in more than a quarter of pregnant women with gestational diabetes in an Australian study. NSW researchers made the findings in 108 women attending an obstetrics clinic, who had transient elastography (TE) after 24 weeks gestation with a diagnosis of GDM established on a 75-gram oral ...
One in four women with gestational diabetes have MAFLD: FibroScan study
By Mardi Chapman
25 Mar 2021